ValorQ4, 24TTMSelling/general/admin expenses131.3 M506 MResearch & development32.1 M126.4 MOperating income83.9 M310 MNon-Operating Income, Total-10 M-37.4 MInterest expense, net of interest capitalized7.4 M33.2 MNon-Operating Income, excl. Interest Expenses-17.4 M-70.6 MUnusual income/expense——Pretax income73.9 M272.6 MEquity in earnings——Taxes12 M64.9 MNon-controlling/minority interest——After tax other income/expense——Net income before discontinued operations61.9 M207.7 MDiscontinued operations6.4 M-359.2 MNet income68.3 M-151.5 MDilution adjustment——Preferred dividends——Diluted net income available to common stockholders68.3 M-151.5 MBasic earnings per share (Basic EPS)1.25-2.83Diluted earnings per share (Diluted EPS)1.22-2.8Average basic shares outstanding53.6 M215.9 MDiluted shares outstanding54.2 M218.2 MEBITDA97.5 M348.8 MEBIT83.9 M310 MCost of revenue165.2 M581.7 MOther cost of goods sold——Depreciation & amortization (cash flow)13.6 M38.8 M
Masimo Corporation
Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive sensors, and related software platforms used in hospital and home settings. Masimo has also operated in the consumer audio and wearable device markets. In 2026, Danaher Corporation agreed to acquire the company for $10 billion.